Agilent Technologies, Inc. $A Shares Sold by Curated Wealth Partners LLC

Key Points

• Curated Wealth Partners cut its Agilent stake by 98.5% during the third quarter, selling 278,810 shares and retaining 4,134 shares valued at approximately $712,000.
• Agilent reported quarterly EPS of $1.62, exceeding the $1.49 analyst estimate, while revenue rose 8.1% year over year to $1.88 billion. The company issued fiscal 2026 EPS guidance of $6.18–$6.21.
• Analyst sentiment remains broadly positive, with 15 Buy ratings and four Holds and a consensus price target of $173.65; Agilent also announced a quarterly dividend of $0.255 per share, yielding about 0.6%.

Curated Wealth Partners LLC lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 98.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,134 shares of the medical research company's stock after selling 278,810 shares during the quarter. Curated Wealth Partners LLC's holdings in Agilent Technologies were worth $712,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. WealthPlan Investment Management LLC bought a new position in shares of Agilent Technologies in the third quarter valued at approximately $245,000. Mather Group LLC. increased its stake in shares of Agilent Technologies by 8.0% in the third quarter. Mather Group LLC. now owns 2,907 shares of the medical research company's stock valued at $501,000 after buying an additional 215 shares in the last quarter. Godsey & Gibb Inc. raised its holdings in shares of Agilent Technologies by 1.5% in the third quarter. Godsey & Gibb Inc. now owns 178,388 shares of the medical research company's stock valued at $30,738,000 after buying an additional 2,660 shares during the last quarter. Generate Investment Management Ltd raised its stake in shares of Agilent Technologies by 10.8% in the third quarter. Generate Investment Management Ltd now owns 89,766 shares of the medical research company's stock worth $15,468,000 after acquiring an additional 8,720 shares during the last quarter. Finally, First Citizens Bank & Trust Co. bought a new stake in shares of Agilent Technologies during the third quarter valued at approximately $1,080,000.

Agilent Technologies Trading Up 0.9%

A stock opened at $175.54 on Friday. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $177.05. The company has a market capitalization of $49.49 billion, a PE ratio of 34.56, a price-to-earnings-growth ratio of 2.65 and a beta of 1.21. The company's 50-day simple moving average is $158.46 and its 200 day simple moving average is $137.30. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. Agilent Technologies's revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be given a dividend of $0.2550 per share. This represents a $1.02 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, October 6th. Agilent Technologies's dividend payout ratio (DPR) is currently 20.08%.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Analyst price-target support: Morgan Stanley forecast meaningful appreciation for Agilent shares, while TD Cowen raised its price target. The revisions reinforce positive Wall Street sentiment and suggest analysts see additional upside despite the stock’s recent gains. Morgan Stanley Forecasts Strong Price Appreciation for Agilent Technologies Stock Agilent Technologies Stock Gets Price Target Bump from TD Cowen
• Positive Sentiment: Proscia acquisition expands AI capabilities: Agilent agreed to acquire pathology-software company Proscia for $240 million upfront, with the total consideration potentially reaching $270 million through milestones. The deal would strengthen Agilent’s position in AI-enabled digital pathology and scientific intelligence, adding a potentially faster-growing software component to its tools and diagnostics portfolio. Agilent Technologies to Acquire Proscia
• Positive Sentiment: Favorable market backdrop: A new industry report projects the global metabolomics market will expand at a 17.3% compound annual growth rate through 2030. Agilent is identified as one of the companies positioned to benefit as laboratories adopt AI-assisted diagnostics and advanced analytical technologies. Global Metabolomics Market Report 2026
• Neutral Sentiment: China expansion: Agilent plans to expand its capabilities in China, which could improve access to regional demand and support longer-term growth. However, execution, regulatory and geopolitical risks remain considerations for investors. Agilent to Expand Capabilities in China
• Negative Sentiment: Acquisition costs and integration risk: The Proscia transaction requires substantial capital and may create integration and milestone-payment risks before it contributes materially to earnings. With Agilent already trading at a premium valuation, investors may scrutinize the deal’s execution and return on investment.

Insider Activity

In other news, Director Mikael Dolsten sold 634 shares of the business's stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the transaction, the director owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Analyst Upgrades and Downgrades

A number of brokerages have commented on A. The Goldman Sachs Group increased their price objective on Agilent Technologies from $155.00 to $175.00 and gave the company a "buy" rating in a research report on Thursday, August 27th. Morgan Stanley increased their price target on Agilent Technologies from $175.00 to $190.00 and gave the stock an "overweight" rating in a report on Tuesday. Barclays boosted their price objective on Agilent Technologies from $175.00 to $195.00 and gave the company an "overweight" rating in a research report on Wednesday, October 7th. JPMorgan Chase & Co. raised their price objective on shares of Agilent Technologies from $180.00 to $190.00 and gave the stock an "overweight" rating in a report on Thursday, August 27th. Finally, UBS Group assumed coverage on Agilent Technologies in a research note on Wednesday, September 9th. They issued a "neutral" rating and a $165.00 price target on the stock. Fifteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $173.65.

Agilent Technologies Profile

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company's products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.